Clinical observation of submucosal injection with different doses of dexamethasone to improve postoperative symptoms of mandibular third molar extraction

Xiao-feng DAI,Xin HUANG,Liang WANG,You-cheng YU,Shuang YUAN
DOI: https://doi.org/10.7501/j.issn.1674-5515.2017.05.036
2017-01-01
Abstract:Objective To study the clinical effect of submucosal injection of dexamethasone to improve postoperative symptoms of mandibular third molar extraction.Methods Patients (156 cases) with mandibular third molar extraction in Zhongshan Hospital of Fudan University and Shanghai Jingan Dental Clinic from August 2016 to November 2016 were randomly divided into control group (53 cases), dexamethasone 4 mg group (51 cases) and dexamethasone 8 mg group (52 cases). Patients in the control group were submucosal injected with normal saline within 1 cm range of mandibular third molar. Patients in the dexamethasone 4 mg group were submucosal injected with 4 mg Dexamethasone Sodium Phosphate Injection within 1 cm range of mandibular third molar. Patients in the dexamethasone 8 mg group were submucosal injected with 8 mg Dexamethasone Sodium Phosphate Injection within 1 cm range of mandibular third molar. After treatment, the postoperative symptom score (PoSSe) was evaluated, and postoperative swelling and maximum mouth opening degree among three groups were compared. After treatment, the scores of diet, speech, swelling, pain, daily life and total scores in the dexamethasone 4 mg and dexamethasone 8 mg group were lower than those in the control group, and there were difference among three groups (P < 0.05). The observational indexes in the dexamethasone 8 m group were significantly better than those in the dexamethasone 4 mg group, with significant difference between two groups (P<0.05). After treatment, the 1 grade swelling percentage in dexamethasone 8 mg group was significantly higher than those in the control and dexamethasone 4 mg groups, but the 3 and 4 grade swelling percentage in dexamethasone 8 mg group was significantly lower than those in the control and dexamethasone 4 mg groups, and there was difference among three groups (P < 0.05). After 1 week of surgery, the maximum mouth opening degree in the dexamethasone 4 mg and dexamethasone 8 mg group were significantly bigger than that in the control group, and there was difference among three groups (P < 0.05).Conclusion Submucosal injection with dexamethasone in mandibular third molar can improve postoperative symptoms, can decrease postoperative swelling, increase maximum mouth opening degree after 1 week of surgery, and dexamethasone with dose of 8 mg is better than dexamethasone with dose of 4 mg, which has a certain clinical application value.
What problem does this paper attempt to address?